Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04046965 · ClinicalTrials.gov registry record
American Indian and Alaska Native Head Start Family and Child Experiences Survey (AIAN FACES 2019)
A clinical trial of Head Start Participation, sponsored by Mathematica Policy Research.
- Completed
- Registry status
- 1,587
- Enrollment target
- 1
- Study location
NCT04046965: Completed study of Head Start Participation, sponsored by Mathematica Policy Research.
NCT04046965 is a study of Head Start Participation that has completed, run by Mathematica Policy Research. The registered enrollment target is 1,587 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04046965, a study of Head Start Participation, has completed, sponsored by Mathematica Policy Research.
- COMPLETED
- Registry status
- 1,587 participants
- Enrollment target
- 1
- Study location
Study Summary
The American Indian and Alaska Native Head Start Family and Child Experiences Survey (AIAN FACES) 2019 builds on AIAN FACES 2015 (NCT03842111), which was the first national study children and families participating in Region XI Head Start. In consultation with the AIAN FACES Workgroup, Mathematica developed instruments and data collection procedures to assess the school readiness skills of 720 children and survey their parents and Region XI Head Start teachers in fall 2019 and spring 2020; conduct observations in those children's Region XI Head Start classrooms; and survey Region XI Head Start staff in spring 2020. Due to the COVID-19 pandemic, spring 2020 child assessments and classroom observations were canceled after two weeks, while surveys of parents and staff continued.
Primary Outcome
Children's English language proficiency were assessed during week-long site visits using Preschool Language Assessment Survey (preLAS 2000): Simon Says and Art Show. See Duncan and DeAvila for more information on the scores and technical properties.
Conditions Studied
Study Locations (1)
District of Columbia
- Mathematica Policy Research - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,587 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2020-07-31 |
What the finished NCT04046965 record still lists
NCT04046965 is an observational study that tracks outcomes without assigning an intervention. Its 1,587 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Head Start Participation appearing as the primary indexed condition, and to 0 interventions.
NCT04046965 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT04046965 about?
NCT04046965 is a clinical study titled "American Indian and Alaska Native Head Start Family and Child Experiences Survey (AIAN FACES 2019)". The American Indian and Alaska Native Head Start Family and Child Experiences Survey (AIAN FACES) 2019 builds on AIAN FACES 2015 (NCT03842111), which was the first national study children and families participating in Region XI Head Start. In consultation with the AIAN FACES Workgroup, Mathematica d...
What is the current status of trial NCT04046965?
This trial is currently completed. The enrollment target is 1,587 participants. The study started on 2019-09-01. Estimated completion is 2020-07-31.
What conditions does trial NCT04046965 study?
This clinical trial studies the following conditions: Head Start Participation.
Who is sponsoring clinical trial NCT04046965?
This trial is sponsored by Mathematica Policy Research, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04046965 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Head Start Participation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05552222 · 1,590 participants · Phase 3
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
- NCT06632457 · 1,590 participants · Phase 3
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- NCT05243797 · 1,594 participants · Phase 3
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
- NCT05483855 · 1,580 participants
Telehealth-delivered HealthcaRe to ImproVe Care
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI